WKN: | A2QAME |
ISIN: | US92556V1061 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Viatris-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 22. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2009 | 6,85 | 12,76 | 86,28% |
2 | 1997 | 5,91 | 9,32 | 57,70% |
3 | 2001 | 12,18 | 18,89 | 55,09% |
4 | 2014 | 30,85 | 47,01 | 52,38% |
5 | 2013 | 20,61 | 30,85 | 49,68% |
6 | 2003 | 14,36 | 20,20 | 40,67% |
7 | 2005 | 12,72 | 16,70 | 31,29% |
8 | 1998 | 9,32 | 11,82 | 26,82% |
9 | 2010 | 12,76 | 15,92 | 24,76% |
10 | 2012 | 16,77 | 20,61 | 22,90% |
11 | 2024 | 9,68 | 11,84 | 22,31% |
12 | 2000 | 11,11 | 12,18 | 9,63% |
13 | 2015 | 47,01 | 50,29 | 6,98% |
14 | 2011 | 15,92 | 16,77 | 5,34% |
15 | 2017 | 36,13 | 35,00 | -3,13% |
16 | 1999 | 11,82 | 11,11 | -6,01% |
17 | 2023 | 10,49 | 9,68 | -7,72% |
18 | 2006 | 16,70 | 14,91 | -10,72% |
19 | 2022 | 11,98 | 10,49 | -12,44% |
20 | 2021 | 14,30 | 11,98 | -16,22% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2007 | 14,91 | 9,28 | -37,76% |
2 | 2004 | 20,20 | 12,72 | -37,03% |
3 | 2018 | 35,00 | 24,20 | -30,86% |
4 | 2025 | 11,84 | 8,33 | -29,65% |
5 | 2019 | 24,20 | 17,30 | -28,51% |
6 | 2016 | 50,29 | 36,13 | -28,16% |
7 | 2008 | 9,28 | 6,85 | -26,19% |
8 | 2002 | 18,89 | 14,36 | -23,98% |
9 | 2020 | 17,30 | 14,30 | -17,34% |
10 | 2021 | 14,30 | 11,98 | -16,22% |
11 | 2022 | 11,98 | 10,49 | -12,44% |
12 | 2006 | 16,70 | 14,91 | -10,72% |
13 | 2023 | 10,49 | 9,68 | -7,72% |
14 | 1999 | 11,82 | 11,11 | -6,01% |
15 | 2017 | 36,13 | 35,00 | -3,13% |
16 | 2011 | 15,92 | 16,77 | 5,34% |
17 | 2015 | 47,01 | 50,29 | 6,98% |
18 | 2000 | 11,11 | 12,18 | 9,63% |
19 | 2024 | 9,68 | 11,84 | 22,31% |
20 | 2012 | 16,77 | 20,61 | 22,90% |